Pharmaceutical Technology ePT Weekly: Having trouble viewing this e-mail? Click here.

News Industry Briefs Webcasts Events About Us

Webcast:Improving Cell Culture Productivity: Best Practices for Automation and Control Sponsored by Parker Hannifan Webcast:Application of QWBA and Short-Lived Isotopes in the Drug Development Paradigm Sponsored by MPI Research Webcast: API Development: Risk and Control of Genotoxic Impurities Sponsored by Neuland MORE WEBCASTS BIO-Europe Spring 2013 March 11–13, 2013 Barcelona, Spain Informex February 19–22, 2013 California, USA   Join our online community Advertisement: Accelerate Sterile and Non-Sterile Clinical Trial Manufacturing with Single-Use Technologies Live Webcast: Wednesday, March 6, 2013 at 11:00 AM ET Register Free at http://www.pharmtech.com/ accelerate

January 24, 2013 PharmTech.com PRINT SUBSCRIBE DIGITAL SUBSCRIBE FDA Approves Influenza Vaccine Manufactured with Novel Technology FDA has approved Protein Sciences’s FluBlok, a seasonal influenza vaccine made with a novel technology that uses recombinant DNA and a modified baculovirus. FTC Reports Increase in Anticompetitive Activities Among Drug Makers In a new report issued by the Federal Trade Commission (FTC), FTC analysts reported that the number of potentially anticompetitive patent dispute settlements between branded and generic drug companies increased from 28 in 2011 to 40 in 2012. Rutgers University Research Center and Janssen Develop Continuous Manufacturing Process Researchers in the Engineering Research Center for Structured Organic Particulate Systems at Rutgers University have collaborated with Janssen to develop a direct-compaction line using continuous manufacturing principles. FDA's Position on Abuse-Deterrent Opioid Formulations Becomes Clearer With the release of a draft guidance on the evaluation and labeling of abuse-deterrent opioid formulations, FDA is one step closer to clarifying its thinking on acceptable formulations for this product class. Root Causes of R&D Inefficiency Must be Identified, Says Report Drug developers need to fully identify and address root causes of R&D inefficiency if they want to replenish their sparse R&D pipelines, according to the Tufts Center for the Study of Drug Development. Advertisement: Together: It's how we work. It's how we help Pharma Succeed. Look to Agilent for real world solutions that help pharmaceutical companies discover more rapidly and more efficiently. The Agilent RapidFire High-throughput System and 6550 iFunnel Q-TOF mass spec helped one lab reduce a week of work to 4.5 hours, transforming their productivity. Discover more, and request your free ADME Solutions Guide at our new pharma web page: www.agilent.com/chem/togetherADME Amgen has announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore. Over the next several years, Amgen anticipates investing approximately $200 million to build the facility. Accelrys, a provider of scientific innovation lifecycle-management software, has agreed to acquire Vialis, a systems integrator serving the pharmaceutical, biotechnology, chemicals, and agroscience industries. Almac has completed its Knowledge Transfer Partnership (KTP) with Queens University Belfast intended to develop, improve, and embed bioprocesses to facilitate the delivery of novel products for its biocatalysis business. Daiichi Sankyo and Ranbaxy Laboratories have agreed to integrate their business operations in Thailand, to leverage and maximize the synergies of the hybrid business model, which is expected to commence business on Apr. 1, 2013. Read More Industry Briefs.

What area do you think will see increased regulatory attention and enforcement in 2013? Foreign APIs 32%   GMP inspections 19%       Manufacturing processes 13%       Counterfeit medicines 28%       Social media and digital marketing 8% This week we would like to know... Which of the following has had the most significant advances in PAT over the last 5 years? Contact Us Click here to contact editorial. Click here to contact sales.

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |